A hospital-based exercise program to improve body composition, strength, and abdominal adiposity in 2 HIV-infected children

AIDS Reader

Volumn 17, Issue 9, 2007, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUSCLE STRENGTH; OBESITY; OXYGEN CONSUMPTION; RESISTANCE TRAINING; SCHOOL CHILD; SKINFOLD THICKNESS; STRENGTH;

EID: 84964597455     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;314:1-27.
2. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994;43:1-10.
3. Erikssen G, Liestöl K, Björnholt J, et al. Changes in physical fitness and changes in mortality. Lancet. 1998;352:759-762.
4. Shangold MM. Exercise in the menopausal woman. Obstet Gynecol. 1990;75(4 suppl):53S-58S.
5. Bell MJ, Lineker SC, Wilkins AL, et al. A randomized controlled trial to evaluate the efficacy of community based physical therapy in the treatment of people with rheumatoid arthritis. J Rheumatol. 1998;25:231-237.
6. Agurs-Collins TD, Kumanyika SK, Ten Have TR, Adams-Campbell LL. A randomized controlled trial of weight reduction and exercise for diabetes management in older African-American subjects. Diabetes Care. 1997;20:1503-1511.
7. Centers for Disease Control and Prevention. Update: prevalence of overweight among children, adolescents, and adults United States, 1988-1994. MMWR. 1997;46:198-202.
8. Guidelines for school and community programs to promote lifelong physical activity among young people. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. J Sch Health. 1997;67:202-219.
9. Malina RM. Physical activity: relationship to growth, maturation, and physical fitness. In: Bouchard C, Shephard RJ, Stephens T, eds. Physical Activity, Fitness, and Health. International Proceedings and Consensus Statement. Champaign, Ill: Human Kinetics; 1994:918-930.
10. Sánchez Bayle M, Aranguren Jiménez A, Cabello Gómez P, Huertas Sevillano C. A longitudinal study of physical exercise practice in children. The influence of age, gender, and socioeconomic level. The Working Group on Cardiovascular Risk Factors in Childhood and Adolescence [in Spanish]. An Esp Pediatr. 1998;48:25-27.
11. Uusi-Rasi K, Haapasalo H, Kannus P, et al. Determinants of bone mineralization in 8 to 20 year old Finnish females. Eur J Clin Nutr. 1997;51:54-59.
12. Faigenbaum AD, Zaichkowsky LD, Westcott WL, et al. The effects of a twice-a-week strength training program on children. Pediatr Exerc Sci. 1993;5:339-346.
13. Faigenbaum AD, Kraemer WJ, Cahill B, et al. Youth resistance training: position statement paper and literature review. Strength Cond. 1996;18:62-71.
14. Johnson JE, Anders GT, Blanton HM, et al. Exercise dysfunction in patients seropositive for the human immunodeficiency virus. Am Rev Respir Dis. 1990;141:618-622.
15. MacArthur RD, Levine SD, Birk TJ. Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc. 1993;25:684-688.
16. Spence DW, Galantino ML, Mossberg KA, Zimmerman SO. Progressive resistance exercise: effect on muscle function and anthropometry of a select AIDS population. Arch Phys Med Rehabil. 1990;71:644-648.
17. Roubenoff R, Suri J, Raymond J, et al. Feasibility of increasing lean body mass in HIV-infected adults using progressive resistance training [abstract]. Nutrition. 1997;13:271.
18. Agin D, Gallagher D, Wang J, et al. Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV. AIDS. 2001;15:2431-2440.
19. Rigsby LW, Dishman RK, Jackson AW, et al. Effects of exercise training on men seropositive for the human immunodeficiency virus-1. Med Sci Sports Exerc. 1992;24:6-12.
20. LaPerriere A, Fletcher MA, Antoni MH, et al. Aerobic exercise training in an AIDS risk group. Int J Sports Med. 1991;12(suppl 1):S53-S57.
21. Roubenoff R, Schmitz H, Bairos L, et al. Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle. Clin Infect Dis. 2002;34:390-393.
22. Yarasheski KE, Roubenoff R. Exercise treatment for HIV-associated metabolic and anthropomorphic complications. Exerc Sport Sci Rev. 2001;29:170-174.
23. Thöni GJ, Fedou C, Brun JF, et al. Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia. Diabetes Metab. 2002;28:397-404.
24. Miller TL, Easley KA, Zhang W, et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics. 2001;108:1287-1296.
25. Miller TL, Evans SJ, Orav EJ, et al. Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr. 1993;57:588-592.
26. Missmer SA, Spiegelman D, Gorbach SL, Miller TL. Predictors of change in the functional status of children with human immunodeficiency virus infection. Pediatrics. 2000;106:E24.
27. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106:286-288.
28. Miller TL, Mawn BE, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics. 2001;107:E77.
29. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998;351:1881-1883.
30. Saint-Marc T, Partisani M, Poizot-Martin I, et al. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside-analogue therapy. AIDS. 1999;13:1659-1667.
31. Arpadi SM, Cuff PA, Horlick M, et al. Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+-lymphocyte count and CD4+-lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr. 2001;27:30-34.
32. Jaquet D, Lévine M, Ortega-Rodriguez E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000;14:2123-2128.
33. Sharma TS, Orav EJ, Duggan C, et al. Visceral adiposity and cardiac risk profiles in human immunodeficiency virus-1 infected children [abstract]. Pediatr Res. 2006.
34. McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18:1753-1768.
35. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS. 2004;18:1443-1451.
36. Friis-Møller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
37. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32:130-139.
38. Subsai K, Kanoksri S, Siwaporn C, et al. Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study. Eur J Neurol. 2006;13:233-239.
39. Volek JS, Gomez AL, Love DM, et al. Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition. Eur J Clin Nutr. 2002;56:585-592.
40. Miller TL, Awnetwant EL, Evans S, et al. Gastrostomy tube supplementation for HIV-infected children. Pediatrics. 1995;96:696-702.
41. Dreimane D, Gallagher K, Nielsen K, et al. Growth hormone exerts potent anabolic effects in an adolescent with human immunodeficiency virus wasting. Pediatr Infect Dis J. 1999;18:167-169.